Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Autologous Haematopoietic Stem Cell Transplantation Is a Highly Effective Second Line of Treatment for Patients with Diffuse Large B-Cell Lymphoma

Malgorzata Krawczyk-Kulis, Anna Kopinska, Marek Seweryn, Malgorzata Sobczyk-Kruszelnicka, Slawomira Kyrcz-Krzemien, MD, PhD,

Blood (2011) 118 (21): 4519.

https://doi.org/10.1182/blood.V118.21.4519.4519

Published: 2011

Journal Articles

ATG Use Is Associated with Frequent Occurrence of Positive Blood Cultures in Patients in the Early Phase After Hematopoietic Stem Cell Transplantation

Marek Seweryn, Urszula Jarosz, Malgorzata Krawczyk-Kulis, Miroslaw Markiewicz, Grzegorz Helbig, Grazyna Bober, Slawomira Kyrcz-Krzemien

Blood (2011) 118 (21): 4564.

https://doi.org/10.1182/blood.V118.21.4564.4564

Published: 2011

Journal Articles

The Use of Purine Analogues During Induction and Consolidation Therapy of Acute Myeloid Leukemia Does Not Increase the Need for More Frequent Transfusions of Red Blood Cell Concentrates, Platelet Concentrates and Fresh Frozen Plasma

Marek Seweryn, MD, Dariusz Kata, MD, Slawomira Kyrcz-Krzemien, MD, PhD

Blood (2010) 116 (21): 4358.

https://doi.org/10.1182/blood.V116.21.4358.4358

Published: 2010

Journal Articles

Incidence, Clinical Presentations and Management of Isolated Extramedullary Relapses After Allogeneic Hematopoietic Stem Cell Transplantation for Acute and Chronic Leukemias: An Updated Single-Center Analysis of 612 Patients.

Dariusz Kata, Miroslaw Markiewicz, Tomasz Czerw, Marek Seweryn, Slawomira Kyrcz-Krzemien, MD, PhD

Blood (2010) 116 (21): 4506.

https://doi.org/10.1182/blood.V116.21.4506.4506

Published: 2010

Journal Articles

The Use of Purine Analogues Does Not Aggravate Infectious Complications During Induction and Consolidation Therapy of Acute Myeloid Leukemia.

Marek Seweryn, Jerzy Wojnar, Dariusz Kata, Slawomira Kyrcz-Krzemien

Blood (2009) 114 (22): 1011.

https://doi.org/10.1182/blood.V114.22.1011.1011

Published: 2009

Journal Articles

Incidence, Treatment and Outcome of Isolated Extramedullary Relapses after Allogeneic Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic and Myeloid Leukemias: Single-Center Experience with 324 Patients

Dariusz Kata, Slawomira Kyrcz-Krzemien, Tomasz Czerw, Maria Sadus-Wojciechowska, Marek Seweryn, Grzegorz Helbig

Blood (2008) 112 (11): 4302.

https://doi.org/10.1182/blood.V112.11.4302.4302

Published: 2008

Journal Articles

The Reduction of Leukemic Blasts In Bone Marrow Aspirate on Day 6 of Remission Induction Treatment Is Predictive for Complete Remission Rate and Survival in Adult Acute Myeloid Leukemia: The Results of Multicenter, Prospective Polish Adult Leukemia Group Study.

Jerzy Holowiecki, Sebastian Grosicki, Slawomira Kyrcz-Krzemien, Kazimierz Kuliczkowski, Marek Kielbinski, Aleksander B. Skotnicki, Beata Piatkowska-Jakubas, Andrzej Hellmann, MD, PhD, Agnieszka Wierzbowska, Marek Seweryn, Beata Stella-Holowiecka, Maria Sadus-Wojciechowska

Blood (2008) 112 (11): 1950.

https://doi.org/10.1182/blood.V112.11.1950.1950

Published: 2008

NARROW

Autologous Haematopoietic Stem Cell Transplantation Is a Highly Effective Second Line of Treatment for Patients with Diffuse Large B-Cell Lymphoma

ATG Use Is Associated with Frequent Occurrence of Positive Blood Cultures in Patients in the Early Phase After Hematopoietic Stem Cell Transplantation

The Use of Purine Analogues During Induction and Consolidation Therapy of Acute Myeloid Leukemia Does Not Increase the Need for More Frequent Transfusions of Red Blood Cell Concentrates, Platelet Concentrates and Fresh Frozen Plasma

Incidence, Clinical Presentations and Management of Isolated Extramedullary Relapses After Allogeneic Hematopoietic Stem Cell Transplantation for Acute and Chronic Leukemias: An Updated Single-Center Analysis of 612 Patients.

The Use of Purine Analogues Does Not Aggravate Infectious Complications During Induction and Consolidation Therapy of Acute Myeloid Leukemia.

Incidence, Treatment and Outcome of Isolated Extramedullary Relapses after Allogeneic Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic and Myeloid Leukemias: Single-Center Experience with 324 Patients

The Reduction of Leukemic Blasts In Bone Marrow Aspirate on Day 6 of Remission Induction Treatment Is Predictive for Complete Remission Rate and Survival in Adult Acute Myeloid Leukemia: The Results of Multicenter, Prospective Polish Adult Leukemia Group Study.

Email alerts

ASH Publications

American Society of Hematology

Autologous Haematopoietic Stem Cell Transplantation Is a Highly Effective Second Line of Treatment for Patients with Diffuse Large B-Cell Lymphoma

ATG Use Is Associated with Frequent Occurrence of Positive Blood Cultures in Patients in the Early Phase After Hematopoietic Stem Cell Transplantation

The Use of Purine Analogues During Induction and Consolidation Therapy of Acute Myeloid Leukemia Does Not Increase the Need for More Frequent Transfusions of Red Blood Cell Concentrates, Platelet Concentrates and Fresh Frozen Plasma

Incidence, Clinical Presentations and Management of Isolated Extramedullary Relapses After Allogeneic Hematopoietic Stem Cell Transplantation for Acute and Chronic Leukemias: An Updated Single-Center Analysis of 612 Patients.

The Use of Purine Analogues Does Not Aggravate Infectious Complications During Induction and Consolidation Therapy of Acute Myeloid Leukemia.

Incidence, Treatment and Outcome of Isolated Extramedullary Relapses after Allogeneic Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic and Myeloid Leukemias: Single-Center Experience with 324 Patients

The Reduction of Leukemic Blasts In Bone Marrow Aspirate on Day 6 of Remission Induction Treatment Is Predictive for Complete Remission Rate and Survival in Adult Acute Myeloid Leukemia: The Results of Multicenter, Prospective Polish Adult Leukemia Group Study.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only